PMV Pharmaceuticals, Inc.
PMVP
$1.38
$0.042.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.73% | -3.45% | 21.58% | -9.53% | -1,648.56% |
| Total Depreciation and Amortization | -25.00% | -8.11% | -15.38% | -91.64% | -91.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.97% | 47.01% | -83.48% | -17.65% | -25.37% |
| Change in Net Operating Assets | 20.27% | -73.09% | -99.10% | -55.87% | 193.55% |
| Cash from Operations | 20.35% | -7.74% | -3.17% | -17.70% | -1,045.31% |
| Capital Expenditure | -- | -- | 73.21% | 200.00% | -175.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -96.55% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -211.49% | -27.49% | 143.59% | -29.64% | 371.29% |
| Cash from Investing | -211.30% | -27.48% | 138.17% | -29.74% | 372.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 38.83% | -- | 127.91% | -- | -26.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 38.83% | -- | 127.91% | -- | -26.95% |
| Foreign Exchange rate Adjustments | 100.00% | -71.43% | 90.91% | -50.00% | -116.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -269.57% | -89.04% | 118.80% | -2,842.96% | -927.29% |